Q BioMed Inc (QBIO)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Q BioMed 1 Year Total Returns (Daily): -96.15% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | -96.15% |
| April 30, 2024 | -98.35% |
| April 29, 2024 | -98.35% |
| April 26, 2024 | -98.55% |
| April 25, 2024 | -98.58% |
| April 24, 2024 | -98.58% |
| April 23, 2024 | -98.57% |
| April 22, 2024 | -98.57% |
| April 19, 2024 | -98.60% |
| April 18, 2024 | -98.57% |
| April 17, 2024 | -99.32% |
| April 16, 2024 | -99.35% |
| April 15, 2024 | |
| April 12, 2024 | |
| April 11, 2024 | |
| April 10, 2024 | |
| April 09, 2024 | |
| April 08, 2024 | |
| April 05, 2024 | |
| April 04, 2024 | |
| April 03, 2024 | -98.00% |
| April 02, 2024 | -97.79% |
| April 01, 2024 | -97.79% |
| March 28, 2024 | -98.06% |
| March 27, 2024 | -97.97% |
| Date | Value |
|---|---|
| March 26, 2024 | -98.08% |
| March 25, 2024 | -98.08% |
| March 22, 2024 | -97.89% |
| March 21, 2024 | -98.00% |
| March 20, 2024 | -98.74% |
| March 19, 2024 | -98.53% |
| March 18, 2024 | -98.53% |
| March 15, 2024 | -98.56% |
| March 14, 2024 | |
| March 13, 2024 | |
| March 12, 2024 | |
| March 11, 2024 | |
| March 08, 2024 | |
| March 07, 2024 | |
| March 06, 2024 | -97.48% |
| March 05, 2024 | -98.00% |
| March 04, 2024 | -98.00% |
| March 01, 2024 | -99.19% |
| February 29, 2024 | -99.17% |
| February 28, 2024 | -99.17% |
| February 27, 2024 | -99.26% |
| February 26, 2024 | -98.10% |
| February 23, 2024 | -99.12% |
| February 22, 2024 | -99.29% |
| February 21, 2024 | -99.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.72%
Minimum
Jun 20 2023
211.2%
Maximum
Nov 19 2020
-50.52%
Average
-60.23%
Median
1 Year Total Returns (Daily) Benchmarks
| Cantabio Pharmaceuticals Inc | 0.00% |
| NVN Liquidation Inc | -- |
| Affymax Inc | -82.93% |
| Scopus BioPharma Inc | -98.18% |
| Statera BioPharma Inc | -96.68% |